Advocacy
A New Year, and More Advocate Leaders Than Ever Before
Together, we made great strides in 2020 on Capitol Hill, and we are excited to announce that we now have more OCRA Advocate Leaders than ever before speaking up for the ovarian cancer community…
Federal Ovarian Cancer Research Funding is in Jeopardy: Act Now!
Urge your U.S…
Now Accepting Applications for 2021 Advocate Leader Program
Be a voice for the ovarian cancer community. Please note: The deadline for application was December 7, 2021…
OCRA’s Statement on SCOTUS and the Affordable Care Act (ACA)
The Supreme Court is poised to consider California v…
Everything You Need to Know About Johanna’s Law and Reauthorization
An important victory for the ovarian cancer community came in 2006 when Congress passed Johanna’s Law…
The Overview: July 2020
There’s so much happening at OCRA – from groundbreaking research to advocacy work, patient support to fundraising efforts. Starting this summer, we will share periodic highlights so that you can stay up to date on the latest…
Action Alert: Tell Congress to Support Full Funding for OCRP
The Ovarian Cancer Research Program (OCRP) is a cutting-edge program housed within the Department of Defense. Despite a history of successful breakthroughs, the program has long been drastically underfunded…
OCRA Supports The CLINICAL TREATMENT Act (H.R. 913)
For many ovarian cancer patients, clinical trials offer a promising avenue for expanding treatment options and extending survival…
Drawing Upon Strength, Speaking Her Truth | Meet an Advocate Leader
“When something is important to you. Be passionate about it. Stay in their face.” That was the advice Kandis Draw received from her mother over and over as she was growing up…
Action Alert: Tell Your Member of Congress to Co-Sponsor the CLINICAL TREATMENT Act (H.R. 913)
(June 16, 2020) Ovarian cancer is the deadliest gynecologic cancer and fifth leading cause of cancer deaths in women in the United States. There is no effective screening tool and early symptoms are often vague, or altogether absent…
Action Alert: Help Push Forward Treatments in the Time of COVID-19
The novel coronavirus pandemic has impacted the healthcare system on every level. Right now, OCRA is working alongside several cancer advocacy groups to ensure government agencies are aware of COVID-19’s real-life impact on cancer patients…
COVID-19 and Oncology Clinical Trials: An Update
(April 15) The novel coronavirus, COVID-19, has become nearly all consuming. It’s impossible to turn on the news, browse social media, or walk outside without being reminded of the new, albeit temporary, state of the world…